Brittany Bradrick

Brittany Bradrick has a diverse background in the healthcare industry, with a focus on strategy, corporate development, and finance. Brittany currently serves as a Member of the Board of Directors and Audit Chair at Spectrum Pharmaceuticals, Inc. Brittany also holds a position as a Member of the Board of Directors at Dermata Therapeutics, Inc. In their previous role as COO and CFO at Neurelis, Inc., they led various aspects of the company, including finance, investor relations, strategic planning, and project management. Prior to this, they served as an Advisory Board member at AltrixBio Inc. Brittany has also held executive positions at ViaCyte, MedExecWomen, MassMEDIC, Insulet Corporation, and Abbott Diabetes Care, where they gained experience in global business development and corporate strategy. Before joining Abbott Diabetes Care, they worked as an independent life science consultant. Their expertise lies in financial planning and analysis, facilities management, and implementing patient advocacy initiatives.

Brittany Bradrick has an MBA degree in Finance and Accounting from the Cornell Johnson Graduate School of Management. Brittany also holds a Bachelor's degree in Finance (BSBA) from the University of Missouri-Columbia. Further details regarding the specific start and end years for these educational experiences are not provided.